Tal M, Thorens B, Surana M, Fleischer N, Lodish H F, Hanahan D, Efrat S
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142-1479.
Mol Cell Biol. 1992 Jan;12(1):422-32. doi: 10.1128/mcb.12.1.422-432.1992.
High-level expression of the low-Km glucose transporter isoform GLUT-1 is characteristic of many cultured tumor and oncogene-transformed cells. In this study, we tested whether induction of GLUT-1 occurs in tumors in vivo. Normal mouse beta islet cells express the high-Km (approximately 20 mM) glucose transporter isoform GLUT-2 but not the low-Km (1 to 3 mM) GLUT-1. In contrast, a beta cell line derived from an insulinoma arising in a transgenic mouse harboring an insulin-promoted simian virus 40 T-antigen oncogene (beta TC3) expressed very low levels of GLUT-2 but high levels of GLUT-1. GLUT-1 protein was not detectable on the plasma membrane of islets or tumors of the transgenic mice but was induced in high amounts when the tumor-derived beta TC3 cells were grown in tissue culture. GLUT-1 expression in secondary tumors formed after injection of beta TC3 cells into mice was reduced. Thus, high-level expression of GLUT-1 in these tumor cells is characteristic of culture conditions and is not induced by the oncogenic transformation; indeed, overnight culture of normal pancreatic islets causes induction of GLUT-1. We also investigated the relationship between expression of the different glucose transporter isoforms by islet and tumor cells and induction of insulin secretion by glucose. Prehyperplastic transgenic islet cells that expressed normal levels of GLUT-2 and no detectable GLUT-1 exhibited an increased sensitivity to glucose, as evidenced by maximal insulin secretion at lower glucose concentrations, compared with that exhibited by normal islets. Further, hyperplastic islets and primary and secondary tumors expressed low levels of GLUT-2 and no detectable GLUT-1 on the plasma membrane; these cells exhibited high basal insulin secretion and responded poorly to an increase in extracellular glucose. Thus, abnormal glucose-induced secretion of insulin in prehyperplastic islets in mice was independent of changes in GLUT-2 expression and did not require induction of GLUT-1 expression.
低 Km 葡萄糖转运体亚型 GLUT-1 的高水平表达是许多培养的肿瘤细胞和癌基因转化细胞的特征。在本研究中,我们测试了 GLUT-1 在体内肿瘤中是否会被诱导表达。正常小鼠胰岛β细胞表达高 Km(约 20 mM)葡萄糖转运体亚型 GLUT-2,但不表达低 Km(1 至 3 mM)的 GLUT-1。相比之下,源自携带胰岛素启动的猿猴病毒 40 T 抗原癌基因的转基因小鼠(βTC3)中发生的胰岛素瘤的β细胞系,表达的 GLUT-2 水平非常低,但 GLUT-1 水平很高。在转基因小鼠的胰岛或肿瘤的质膜上未检测到 GLUT-1 蛋白,但当肿瘤来源的βTC3 细胞在组织培养中生长时,会大量诱导产生 GLUT-1。将βTC3 细胞注射到小鼠体内后形成的继发性肿瘤中,GLUT-1 的表达降低。因此,这些肿瘤细胞中 GLUT-1 的高水平表达是培养条件的特征,而非由致癌转化诱导;实际上,正常胰岛的过夜培养会导致 GLUT-1 的诱导。我们还研究了胰岛和肿瘤细胞中不同葡萄糖转运体亚型的表达与葡萄糖诱导的胰岛素分泌之间的关系。表达正常水平的 GLUT-2 且未检测到 GLUT-1 的增生前期转基因胰岛细胞对葡萄糖的敏感性增加,与正常胰岛相比,在较低葡萄糖浓度下即可达到最大胰岛素分泌,这证明了这一点。此外,增生性胰岛以及原发性和继发性肿瘤在质膜上表达低水平的 GLUT-2 且未检测到 GLUT-1;这些细胞表现出高基础胰岛素分泌,对细胞外葡萄糖增加的反应较差。因此,小鼠增生前期胰岛中异常的葡萄糖诱导胰岛素分泌与 GLUT-2 表达的变化无关,也不需要诱导 GLUT-1 表达。